Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

225.40 -3.01 (-1.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,543,475
Open 228.42
Bid (Size) 223.80 (1)
Ask (Size) 230.00 (1)
Prev. Close 228.41
Today's Range 225.17 - 230.00
52wk Range 198.64 - 258.45
Shares Outstanding N/A
Dividend Yield 3.12%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Warning! A Housing Market Crash Will Tank These 3 Stocks.
Don't be complacent about a potential black-swan event. A housing market crash would send these three stocks plunging. 
Via InvestorPlace
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
Despite the ongoing worries on Wall Street, these are the best stocks to buy to play the hidden bull market. 
Via InvestorPlace

Performance

YTD
-0.57%
-0.57%
1 Month
-6.20%
-6.20%
3 Month
-8.21%
-8.21%
6 Month
-7.29%
-7.29%
1 Year
+6.00%
+6.00%

More News

Read More
Costco Down After Earnings as Analysts Fret About Company Facing Higher Costs
Via Benzinga
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
Via Investor's Business Daily
Amgen Whale Trades Spotted
Via Benzinga
Amgen's Lumakras Cuts Risk Of Progression By 34% In KRAS-Mutated Lung Cancer Patients
Via Benzinga
AskSlim Market Week - Friday, Sept. 9
Via Talk Markets
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
Via Benzinga
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
Via Investor's Business Daily
Take-Two Gets Beat Down After Leak of Its Popular Grand Theft Auto VI
Via Benzinga
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
Via Benzinga
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
Via Investor's Business Daily
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
Via Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
Via Benzinga
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment
Via InvestorPlace
Here's Why Amgen Shares Are Diving
Via Benzinga
Top Financial Stories Monday, September 12: Netflix Collaborates With Assassin's Creed Maker, Gun Sales Could Soon Be Tracked Via Payment Processors, Xi Jinping To Meet Vladimir Putin In First Foreign Trip And More...
Via Benzinga
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
Via Benzinga
7 Dow Stocks With Superior Fundamentals
Via InvestorPlace
3 Dividend Stocks: A Smarter Way To Boost Your Retirement Income
Via Talk Markets
These 3 S&P 500 Dividend Stocks Have High Compound Annual Growth Rates Through 2024
Via Benzinga
Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years
Via Benzinga
Stocks Extend Losing Streaks Amid Steep Monthly Declines
Via Talk Markets
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.